bioAffinity Technologies shares rise after Nasdaq compliance update

By: Quiver PriceTracker

Posted: 1 day, 10 hours ago / Sept. 9, 2026 4:20 p.m. UTC

BIAF

bioAffinity Technologies, Inc. (BIAF) is up 15.1% today. Here is some analysis on what might have caused this price movement.

Analysis: The most likely catalyst is the company’s September 9, 2026 disclosure that it regained compliance with Nasdaq listing requirements, removing a near-term delisting overhang. Investors also may be reacting to the cancellation of a scheduled Nasdaq hearings panel session and the company’s continued push to expand commercialization of its CyPath Lung test.

Details:

On September 8, 2026, the company received written notice that it had regained compliance with Nasdaq’s minimum bid price rule and its rights and warrants listing rule.

The update means BIAF common stock and BIAFW warrants will remain listed and traded on the Nasdaq Capital Market, subject to ongoing compliance.

The company said the previously scheduled September 8 Nasdaq hearings panel appearance was cancelled after the compliance determination.

Recent company updates have highlighted strategic milestones for CyPath Lung, including expanded surveillance use in lung cancer survivors and an investor presentation planned for mid-September.

Sources:

SEC, bioAffinity Technologies

Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.

EARLY ACCESS

Receive BIAF Data Alerts

Real-time alerts on filings, insider trades, and market signals — before everyone else.

Get Alerts →

$BIAF Hedge Fund Activity

We have seen 14 institutional investors add shares of $BIAF stock to their portfolio, and 8 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

SABBY MANAGEMENT, LLC added 365,647 shares (+inf%) to their portfolio in Q2 2026, for an estimated $296,905
BLACKROCK, INC. added 98,777 shares (+inf%) to their portfolio in Q2 2026, for an estimated $80,206
SUSQUEHANNA INTERNATIONAL GROUP, LLP added 26,870 shares (+inf%) to their portfolio in Q2 2026, for an estimated $21,818
JANE STREET GROUP, LLC added 26,784 shares (+inf%) to their portfolio in Q2 2026, for an estimated $21,748
SCHONFELD STRATEGIC ADVISORS LLC removed 24,413 shares (-100.0%) from their portfolio in Q2 2026, for an estimated $19,823
HRT FINANCIAL LP added 20,834 shares (+inf%) to their portfolio in Q2 2026, for an estimated $16,917
CITADEL ADVISORS LLC removed 11,631 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $44,546

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.